SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

SoundHound AI, Inc. engages in the development, owning, and commercialization of voice, sound, and natural language artificial intelligence technologies and related activities. The company was founded on September 2, 2005 and is headquartered in Santa Clara, CA.

SoundHound AI Inc - Ordinary Shares - Class A

SoundHound AI Inc

SoundHound AI ($SOUN) is trending amid discussions about its recent earnings report and future potential, even with mixed sentiment. While some investors express frustration over recent price action and potential market manipulation, others highlight the company's growth in AI voice solutions, key partnerships, and raised revenue outlook. The community is actively debating the company's long-term prospects and whether it represents a buying opportunity.

Zcash is a decentralized and open-source cryptocurrency that offers privacy and selective transparency of transactions. Zcash payments are published on a public blockchain, but the sender, recipient, and amount of a transaction remain private.  Zcash is based on peer-reviewed cryptographic research, and built by a security-specialized engineering team on an open source platform based on Bitcoin Core's battle-tested codebase. Our improvement over Bitcoin is the addition of privacy. Zcash uses advanced cryptographic techniques, namely zero-knowledge proofs, to guarantee the validity of transactions without revealing additional information about them.  How Zcash works  Zcash encrypts the contents of shielded transactions. Since the payment information is encrypted, the protocol uses a novel cryptographic method to verify their validity.  Zcash uses a zero-knowledge proof construction called a zk-SNARK, developed by our team of experienced cryptographers based on recent breakthroughs in cryptography. These constructions allow the network to maintain a secure ledger of balances without disclosing the parties or amounts involved. Instead of publicly demonstrating spend-authority and transaction values, the transaction metadata is encrypted and zk-SNARKs are used to prove that nobody is cheating or stealing.  Zcash also enables users to send public payments which work similarly to Bitcoin. With the support for both shielded and transparent addresses, users can choose to send Zcash privately or publicly. Zcash payments sent from a shielded address to a transparent address reveal the received balance, while payments from a transparent address to a shielded address protect the receiving value.   Check out CoinBureau for guide on What is ZCash.

Zcash

Zcash is trending as investors flock to privacy coins, with community members discussing its potential to reach $1,000 and comparing it to Bitcoin's early days. A recent Coindesk article has added fuel to the fire, while some traders are pointing to a pullback. The coin's limited supply and focus on shielded transactions are key talking points.

Uniting the six native Japanese dog breeds. Kendu is the keeper of peace, the preserver of life, and the protector of unity. Join the pack!!

Kendu

Kendu is trending as the community rallies around its real-world applications, from Kendu Energy drinks to Kendu Spice.  Enthusiasts are actively discussing the growing number of holders and the brand's increasing visibility. The community emphasizes Kendu's unique position as a permissionless brand with various IRL businesses and initiatives.

Sandisk Corp. engages in the development, manufacture, and provision of storage devices and solutions based on NAND flash technology. Its products include solid state drives, memory cards, and USB flash drives. The company was founded on February 5, 2024 and is headquartered in Milpitas, CA.

Sandisk Corp

SanDisk Corp. is trending due to optimism around its potential in the inference market and high-bandwidth flash memory, with community members drawing comparisons to past high-growth tech stories. Despite some bearish sentiment focused on profitability, bullish traders are pointing to future earnings estimates and significant volume spikes as potential catalysts. The stock's parabolic year-to-date performance and analyst upgrades are fueling FOMO, while others caution about overvaluation and potential manipulation.

Pfizer Inc. is a research-based global biopharmaceutical company, which engages in the discovery, development, manufacture, marketing, sales and distribution of biopharmaceutical products worldwide. The firm works across developed and emerging markets to advance wellness, prevention, treatments and cures that challenge the most feared diseases. The company was founded by Charles Pfizer Sr. and Charles Erhart in 1849 and is headquartered in New York, NY.

Pfizer Inc.

Pfizer Inc

Pfizer's stock is active amid an ongoing bidding war with Novo Nordisk for Metsera, a company focused on obesity drugs, with Pfizer filing lawsuits to challenge Novo's acquisition. The community is discussing the implications of this battle, Pfizer's overall strategy in the weight loss market, and whether the company is overpaying for potential acquisitions. Additionally, the stock's dividend and recent earnings are focal points of conversation.

American Airlines Group, Inc. is a holding company, which engages in the operation of a network carrier through its principal wholly owned mainline operating subsidiary, American. The firm offers air transportation for passengers and cargo. It operates through the following geographical segments: Domestic, Latin America, Atlantic, and Pacific. The company was founded on December 9, 2013, and is headquartered in Fort Worth, TX.

American Airlines Group Inc

American Airlines is trending due to concerns about potential flight disruptions stemming from the ongoing government shutdown and its impact on air traffic controller staffing; community members are discussing the possibility of flight cancellations, revenue hits, and the airline's resilience amid the broader market uncertainty, while some debate the causes and potential end to the shutdown.

Trump Media & Technology Group Corp. engages in operating social media and in the technology business. Its brands include TRUTH Social, TMTG+ and TMTG News. The company was founded on March 28, 2024 and is headquartered in Sarasota, FL.

Trump Media & Technology Group Corp.

DJT is trending amidst discussions about government shutdowns and their impact on social programs like SNAP, with community members debating political motivations and potential economic consequences. Strong opinions on both sides of the aisle regarding Trump's actions and policies are fueling the conversation. Additionally, some traders are analyzing the company's financials, which appear to have missed expectations, and speculating on potential future stock manipulation.

The Wendy’s Co. engages in operating, developing, and franchising a system of quick-service restaurants. It operates through the following segments: Wendy’s U.S., Wendy’s International, and Global Real Estate and Development. The Wendy’s U.S. segment includes the operation and franchising of Wendy’s restaurants in the U.S. The Wendy’s International segment is involved in the operation and franchising of Wendy’s restaurants in countries and territories other than the U.S. The Global Real Estate and Development segment focuses on real estate activity for owned sites and sites leased from third parties. The company was founded by R. David Thomas on November 15, 1969 and is headquartered in Dublin, OH.

Wendy`s Co - Ordinary Shares - Class A

Wendy`s Co

Wendy's ($WEN) is trending as community members discuss its recent earnings beat and subsequent stock reversal, closing lower despite initial gains. Investors are weighing the impact of store closures and a turnaround plan amidst leadership uncertainty, while some speculate on the potential for a short squeeze or buyout.

Viking Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of therapies for metabolic and endocrine disorders. The company was founded by Brian Lian and Michael A. Dinerman on September 24, 2012 and is headquartered in San Diego, CA.

Viking Therapeutics Inc

VKTX is trending amid speculation of a potential acquisition, fueled by ongoing bidding wars in the obesity drug sector and community discussion around $BMY's possible interest. Community members are debating whether Viking will remain independent or be acquired, with some suggesting a price tag of at least $15B, while others discuss potential partnerships and the impact of competitor deals on Viking's valuation.

Delta Air Lines, Inc. engages in the provision of scheduled air transportation for passengers and cargo. It operates through the Airline and Refinery segments. The Airline segment provides scheduled air transportation for passengers and cargo. The Refinery segment provides jet fuel to the airline segment. The company was founded by Collett Everman Woolman in 1928 and is headquartered in Atlanta, GA.

Delta Air Lines, Inc.

Delta Air Lines is trending due to concerns about potential flight disruptions and capacity cuts linked to the ongoing U.S. government shutdown, with air traffic controller staffing shortages being a key issue. The community is closely watching how the situation unfolds and its impact on airline operations and investor sentiment, especially with the Thanksgiving travel season approaching. Some investors feel airlines are undervalued while others are closely watching for an opportunity to invest.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Atea Pharmaceuticals' COVID-19 Treatment Flunks In Late-Stage Study, Blames 'Constantly Evolving' Virus

Atea Pharmaceuticals' Phase 3 SUNRISE-3 trial for bemnifosbuvir in COVID-19 patients did not meet the primary endpoint. The company remains focused on its hepatitis C combination therapy.
read more...

Atea Pharmaceuticals Completes Patient Enrollment in Global Phase 3 SUNRISE-3 Trial Evaluating Oral Antiviral Bemnifosbuvir for COVID-19 in High-Risk Patients

Enrollment Reached Over 2,200 High-Risk Patients in Bemnifosbuvir Monotherapy Cohort Results from SUNRISE-3 Expected in 2H'24 BOSTON, March 27, 2024 (GLOBE NEWSWIRE) -- Atea Pharmaceuticals...

Atea Pharmaceuticals, Inc. (NASDAQ:AVIR) Shares Sold by Federated Hermes Inc.

Federated Hermes Inc. decreased its stake in Atea Pharmaceuticals, Inc. (NASDAQ:AVIR  Free Report) by 0.8% during the 3rd quarter, according to the company in its most recent 13F filing with...

Atea Pharmaceuticals, Inc. (AVIR) Q4 2023 Earnings Call Transcript

Atea Pharmaceuticals, Inc. (AVIR) Q4 2023 Earnings Call Transcript...

Atea Pharmaceuticals Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update

Final Results Confirm 98% Sustained Virologic Response Rate at Week 4 Post-Treatment (SVR4) from Lead-in Cohort in Phase 2 HCV Study Enrollment in Phase 3 SUNRISE-3 Study Has Surpassed 1,400...

Atea Pharmaceuticals to Host Fourth Quarter and Full Year 2023 Financial Results Conference Call on February 28, 2024

BOSTON, Feb. 21, 2024 (GLOBE NEWSWIRE) -- Atea Pharmaceuticals, Inc. (Nasdaq: AVIR) ( Atea ), a clinical-stage biopharmaceutical company engaged in the discovery and development of oral antiviral...

Q1 2024 Earnings Forecast for Atea Pharmaceuticals, Inc. Issued By Leerink Partnrs (NASDAQ:AVIR)

Atea Pharmaceuticals, Inc. (NASDAQ:AVIR  Free Report)  Leerink Partnrs issued their Q1 2024 earnings per share (EPS) estimates for shares of Atea Pharmaceuticals in a research note...

Leerink Partnrs Research Analysts Decrease Earnings Estimates for Atea Pharmaceuticals, Inc. (NASDAQ:AVIR)

Atea Pharmaceuticals, Inc. (NASDAQ:AVIR  Free Report)  Analysts at Leerink Partnrs reduced their FY2023 earnings per share (EPS) estimates for Atea Pharmaceuticals in a report released...

Atea Pharmaceuticals, Inc. Forecasted to Earn Q1 2024 Earnings of ($0.66) Per Share (NASDAQ:AVIR)

Atea Pharmaceuticals, Inc. (NASDAQ:AVIR  Free Report)  Investment analysts at Leerink Partnrs issued their Q1 2024 earnings estimates for shares of Atea Pharmaceuticals in a report...

SG Americas Securities LLC Acquires New Shares in Atea Pharmaceuticals, Inc. (NASDAQ:AVIR)

SG Americas Securities LLC bought a new position in Atea Pharmaceuticals, Inc. (NASDAQ:AVIR  Free Report) in the third quarter, according to its most recent filing with the Securities and...

Atea Pharmaceuticals, Inc. is a clinical stage company, which focuses on discovering, developing, and commercializing antiviral therapeutics. Its product pipelines include Coronaviridae, Flaviviridae, and Paramyxovirdae. The company was founded by Jean-Pierre Sommadossi and David Chu in July 2012 and is headquartered in Boston, MA.

Atea Pharmaceuticals Inc

$ASTS

$RKLB

$BBAI

$NBIS

Which earnings release are you most excited for the week of Nov. 10? 
 
Drop a comment for others.

AVIR
Atea Pharmaceuticals Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Poll

Latest AVIR News

AVIRAtea Pharmaceuticals Inc